{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T14:00:09Z","timestamp":1789048809010,"version":"build-2803163510"},"reference-count":66,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002551","name":"Seoul National University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002551","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Failure Clinics"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.hfc.2025.06.002","type":"journal-article","created":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T11:23:09Z","timestamp":1753701789000},"page":"499-508","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Redefining Left Ventricular Systolic Dysfunction in Hypertrophic Cardiomyopathy"],"prefix":"10.1016","volume":"21","author":[{"given":"Soongu","family":"Kwak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyung-Kwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hfc.2025.06.002_bib1","doi-asserted-by":"crossref","first-page":"563","DOI":"10.4070\/kcj.2022.0159","article-title":"Major clinical issues in hypertrophic cardiomyopathy","volume":"52","author":"Lee","year":"2022","journal-title":"Korean Circ J"},{"key":"10.1016\/j.hfc.2025.06.002_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0227012","article-title":"Trends of the prevalence and incidence of hypertrophic cardiomyopathy in Korea: a nationwide population-based cohort study","volume":"15","author":"Moon","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.hfc.2025.06.002_bib3","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jacc.2021.12.002","article-title":"Diagnosis and evaluation of hypertrophic cardiomyopathy: JACC State-of-the-Art Review","volume":"79","author":"Maron","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2025.06.002_bib4","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1161\/CIRCULATIONAHA.105.583500","article-title":"Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy","volume":"114","author":"Harris","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2025.06.002_bib5","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1161\/CIRCULATIONAHA.119.044366","article-title":"Hypertrophic cardiomyopathy with left ventricular systolic dysfunction: insights from the SHaRe Registry","volume":"141","author":"Marstrand","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2025.06.002_bib6","doi-asserted-by":"crossref","first-page":"e1239","DOI":"10.1161\/CIR.0000000000001250","article-title":"AHA\/ACC\/AMSSM\/HRS\/PACES\/SCMR guideline for the management of hypertrophic cardiomyopathy: a Report of the American heart association\/American College of Cardiology Joint Committee on clinical Practice guidelines","volume":"149","author":"Ommen","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2025.06.002_bib7","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","article-title":"2023 ESC Guidelines for the management of cardiomyopathies","volume":"44","author":"Arbelo","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hfc.2025.06.002_bib8","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1136\/heartjnl-2022-321853","article-title":"Prognosis of patients with hypertrophic cardiomyopathy and low-normal left ventricular ejection fraction","volume":"109","author":"Choi","year":"2023","journal-title":"Heart"},{"key":"10.1016\/j.hfc.2025.06.002_bib9","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1093\/ehjci\/jead177","article-title":"Left ventricular global longitudinal strain as a prognosticator in hypertrophic cardiomyopathy with a low-normal left ventricular ejection fraction","volume":"24","author":"Choi","year":"2023","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.hfc.2025.06.002_bib10","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1136\/bjsports-2020-101987","article-title":"Association of physical activity with all-cause and cardiovascular mortality in 7666 adults with hypertrophic cardiomyopathy (HCM): more physical activity is better","volume":"55","author":"Kwon","year":"2021","journal-title":"Br J Sports Med"},{"key":"10.1016\/j.hfc.2025.06.002_bib11","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jacc.2004.01.054","article-title":"Progressive left ventricular remodeling in patients with hypertrophic cardiomyopathy and severe left ventricular hypertrophy","volume":"44","author":"Thaman","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2025.06.002_bib12","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1161\/CIRCRESAHA.117.311059","article-title":"Hypertrophic cardiomyopathy: genetics, pathogenesis, clinical manifestations, diagnosis, and therapy","volume":"121","author":"Marian","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/j.hfc.2025.06.002_bib13","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.amjcard.2010.03.020","article-title":"Spectrum and clinical significance of systolic function and myocardial fibrosis assessed by cardiovascular magnetic resonance in hypertrophic cardiomyopathy","volume":"106","author":"Olivotto","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hfc.2025.06.002_bib14","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0140-6736(20)31792-X","article-title":"Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"396","author":"Olivotto","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.hfc.2025.06.002_bib15","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.jchf.2023.07.030","article-title":"Mavacamten for obstructive hypertrophic cardiomyopathy with or without hypertension: post-hoc analysis of the EXPLORER-HCM Trial","volume":"12","author":"Wang","year":"2024","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.hfc.2025.06.002_bib16","doi-asserted-by":"crossref","first-page":"S388","DOI":"10.21037\/cdt.2019.02.01","article-title":"Hypertrophic cardiomyopathy: genetics and clinical perspectives","volume":"9","author":"Wolf","year":"2019","journal-title":"Cardiovasc Diagn Ther"},{"key":"10.1016\/j.hfc.2025.06.002_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2023.131574","article-title":"Age-dependent association of metabolic dyslipidemia with clinical expression of hypertrophic cardiomyopathy","volume":"396","author":"Kwak","year":"2024","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hfc.2025.06.002_bib18","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007161","article-title":"Impact of demographic features, lifestyle, and comorbidities on the clinical expression of hypertrophic cardiomyopathy","volume":"6","author":"Finocchiaro","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hfc.2025.06.002_bib19","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1177\/2047487319889714","article-title":"Obesity and metabolic health status are determinants for the clinical expression of hypertrophic cardiomyopathy","volume":"27","author":"Park","year":"2020","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.hfc.2025.06.002_bib20","doi-asserted-by":"crossref","first-page":"3972","DOI":"10.1002\/ehf2.15004","article-title":"Association of Fibrate use with clinical expression of hypertrophic cardiomyopathy","volume":"11","author":"Park","year":"2024","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.hfc.2025.06.002_bib21","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1161\/CIRCHEARTFAILURE.112.967026","article-title":"Patterns of disease progression in hypertrophic cardiomyopathy: an individualized approach to clinical staging","volume":"5","author":"Olivotto","year":"2012","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.hfc.2025.06.002_bib22","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.21037\/atm-20-1817","article-title":"Clinical impact of atrial fibrillation in a nationwide cohort of hypertrophic cardiomyopathy patients","volume":"8","author":"Lee","year":"2020","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.hfc.2025.06.002_bib23","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.cardfail.2011.01.015","article-title":"Risk of sudden death in end-stage hypertrophic cardiomyopathy","volume":"17","author":"Kawarai","year":"2011","journal-title":"J Card Fail"},{"key":"10.1016\/j.hfc.2025.06.002_bib24","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1016\/j.jacc.2020.04.045","article-title":"Outcomes in patients with hypertrophic cardiomyopathy and left ventricular systolic dysfunction","volume":"75","author":"Rowin","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2025.06.002_bib25","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/j.jcmg.2022.03.029","article-title":"Clinical characteristics and prognostic importance of left ventricular apical aneurysms in hypertrophic cardiomyopathy","volume":"15","author":"Lee","year":"2022","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.hfc.2025.06.002_bib26","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.amjcard.2011.03.083","article-title":"Comparison of prevalence, clinical course, and pathological findings of left ventricular systolic impairment versus normal systolic function in patients with hypertrophic cardiomyopathy","volume":"108","author":"Fern\u00e1ndez","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hfc.2025.06.002_bib27","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jacasi.2023.09.002","article-title":"Performance of 2020 AHA\/ACC HCM guidelines and incremental value of myocardial strain for predicting SCD","volume":"4","author":"Lee","year":"2024","journal-title":"JACC Asia"},{"key":"10.1016\/j.hfc.2025.06.002_bib28","doi-asserted-by":"crossref","first-page":"6412","DOI":"10.1038\/s41598-023-33344-3","article-title":"Impact of coronary artery revascularization on long-term outcome in hypertrophic cardiomyopathy patients: a nationwide population-based cohort study","volume":"13","author":"Rhee","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.hfc.2025.06.002_bib29","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.amjcard.2017.12.044","article-title":"Impact of advanced therapies for improving survival to heart transplant in patients with hypertrophic cardiomyopathy","volume":"121","author":"Rowin","year":"2018","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hfc.2025.06.002_bib30","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.amjcard.2014.05.065","article-title":"Significance of sarcomere gene mutations analysis in the end-stage phase of hypertrophic cardiomyopathy","volume":"114","author":"Biagini","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hfc.2025.06.002_bib31","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1093\/eurjhf\/hfr110","article-title":"Genetic basis of end-stage hypertrophic cardiomyopathy","volume":"13","author":"Garcia-Pavia","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.hfc.2025.06.002_bib32","doi-asserted-by":"crossref","first-page":"5137","DOI":"10.3390\/jcm12155137","article-title":"Predictive factors for decreasing left ventricular ejection fraction and progression to the dilated phase of hypertrophic cardiomyopathy","volume":"12","author":"Ishihara","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.hfc.2025.06.002_bib33","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1253\/circj.CJ-24-0049","article-title":"Comparison between heart failure without left ventricular systolic dysfunction and progression to end-stage in hypertrophic cardiomyopathy","volume":"88","author":"Nakagawa","year":"2024","journal-title":"Circ J"},{"key":"10.1016\/j.hfc.2025.06.002_bib34","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.cardfail.2016.03.013","article-title":"Prognosis of low normal left ventricular ejection fraction in an asymptomatic population-based adult cohort: the multiethnic study of atherosclerosis","volume":"22","author":"Yeboah","year":"2016","journal-title":"J Card Fail"},{"key":"10.1016\/j.hfc.2025.06.002_bib35","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.jchf.2016.03.003","article-title":"Prognosis of adults with borderline left ventricular ejection fraction","volume":"4","author":"Tsao","year":"2016","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.hfc.2025.06.002_bib36","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1093\/eurheartj\/ehv529","article-title":"Myocardial strain imaging: how useful is it in clinical decision making?","volume":"37","author":"Smiseth","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hfc.2025.06.002_bib37","doi-asserted-by":"crossref","DOI":"10.4070\/kcj.2024.0213","article-title":"Prognostic implication of left ventricular global longitudinal strain in patients with hypertrophic cardiomyopathy and coexisting hypertension","volume":"55","author":"Kwak","year":"2025","journal-title":"Korean Circ J"},{"key":"10.1016\/j.hfc.2025.06.002_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2022.109838","article-title":"Impact of diabetes mellitus on the outcomes of subjects with hypertrophic cardiomyopathy: a nationwide cohort study","volume":"186","author":"Lee","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.hfc.2025.06.002_bib39","article-title":"Risk of end-stage renal disease in patients with hypertrophic cardiomyopathy: a nationwide population-based cohort study","volume":"9","author":"Lee","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.hfc.2025.06.002_bib40","doi-asserted-by":"crossref","DOI":"10.3346\/jkms.2024.39.e80","article-title":"Mildly reduced renal function is associated with increased heart failure Admissions in patients with hypertrophic cardiomyopathy","volume":"39","author":"Bae","year":"2024","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.hfc.2025.06.002_bib41","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/ejechocard\/jer318","article-title":"Clinical significance of global two-dimensional strain as a surrogate parameter of myocardial fibrosis and cardiac events in patients with hypertrophic cardiomyopathy","volume":"13","author":"Saito","year":"2012","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.hfc.2025.06.002_bib42","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.jcmg.2022.10.005","article-title":"3-Dimensional strain analysis of hypertrophic cardiomyopathy: insights from the NHLBI International HCM Registry","volume":"16","author":"Heydari","year":"2023","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.hfc.2025.06.002_bib43","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1016\/j.jcmg.2018.07.016","article-title":"Prognostic value of global longitudinal strain in hypertrophic cardiomyopathy: a systematic review of existing literature","volume":"12","author":"Tower-Rader","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.hfc.2025.06.002_bib44","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1002\/clc.23928","article-title":"Prognostic value of global longitudinal strain in hypertrophic cardiomyopathy: a systematic review and meta-analysis","volume":"45","author":"Yang","year":"2022","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.hfc.2025.06.002_bib45","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1093\/ehjci\/jeab187","article-title":"Supplementary role of left ventricular global longitudinal strain for predicting sudden cardiac death in hypertrophic cardiomyopathy","volume":"23","author":"Lee","year":"2022","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.hfc.2025.06.002_bib46","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jtcvs.2021.09.058","article-title":"Preoperative left ventricular longitudinal strain predicts outcome of septal myectomy for obstructive hypertrophic cardiomyopathy","volume":"166","author":"Cui","year":"2023","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.hfc.2025.06.002_bib47","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.124.037058","article-title":"Echocardiographic changes following surgical myectomy in severely symptomatic obstructive hypertrophic cardiomyopathy: insights from the SPIRIT-HCM Study","volume":"14","author":"Desai","year":"2025","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hfc.2025.06.002_bib48","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.119.008973","article-title":"Regional variability in longitudinal strain across vendors in patients with cardiomyopathy due to increased left ventricular wall thickness","volume":"12","author":"Sperry","year":"2019","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.hfc.2025.06.002_bib49","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.ahj.2009.06.013","article-title":"Two-dimensional strain analysis in patients with hypertrophic cardiomyopathy and normal systolic function: a 12-month follow-up study","volume":"158","author":"Paraskevaidis","year":"2009","journal-title":"Am Heart J"},{"key":"10.1016\/j.hfc.2025.06.002_bib50","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.006514","article-title":"Incremental prognostic utility of left ventricular global longitudinal strain in hypertrophic obstructive cardiomyopathy patients and preserved left ventricular ejection fraction","volume":"6","author":"Tower-Rader","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hfc.2025.06.002_bib51","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.amjcard.2018.04.038","article-title":"Development of and progression of overt heart failure in nonobstructive hypertrophic cardiomyopathy","volume":"122","author":"Hiemstra","year":"2018","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hfc.2025.06.002_bib52","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.amjcard.2021.04.021","article-title":"Usefulness of global longitudinal strain to predict heart failure progression in patients with nonobstructive hypertrophic cardiomyopathy","volume":"151","author":"Rowin","year":"2021","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hfc.2025.06.002_bib53","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/echo.13547","article-title":"Mechanical dispersion and global longitudinal strain by speckle tracking echocardiography: Predictors of appropriate implantable cardioverter defibrillator therapy in hypertrophic cardiomyopathy","volume":"34","author":"Candan","year":"2017","journal-title":"Echocardiography"},{"key":"10.1016\/j.hfc.2025.06.002_bib54","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.jacc.2018.05.060","article-title":"Late gadolinium enhancement in patients with hypertrophic cardiomyopathy and preserved systolic function","volume":"72","author":"Mentias","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2025.06.002_bib55","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jcmg.2023.07.005","article-title":"Quantitative late gadolinium enhancement cardiac magnetic resonance and sudden death in hypertrophic cardiomyopathy: a meta-analysis","volume":"17","author":"Kiaos","year":"2024","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.hfc.2025.06.002_bib56","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/heartjnl-2014-306555","article-title":"Myocardial fibrosis progression on cardiac magnetic resonance in hypertrophic cardiomyopathy","volume":"101","author":"Choi","year":"2015","journal-title":"Heart"},{"key":"10.1016\/j.hfc.2025.06.002_bib57","doi-asserted-by":"crossref","DOI":"10.21037\/atm.2018.10.07","article-title":"Progressive nature of myocardial fibrosis in pediatric hypertrophic cardiomyopathy: from mutation carrier to myocardial fibrosis","volume":"6","author":"Choi","year":"2018","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.hfc.2025.06.002_bib58","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.121.013556","article-title":"Left atrial reservoir strain-based left ventricular diastolic function grading and incident heart failure in hypertrophic cardiomyopathy","volume":"15","author":"Lee","year":"2022","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.hfc.2025.06.002_bib59","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.124.017185","article-title":"Serial changes in ventricular strain in symptomatic obstructive hypertrophic cardiomyopathy treated with mavacamten: insights from the VALOR-HCM Trial","volume":"17","author":"Desai","year":"2024","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.hfc.2025.06.002_bib60","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jcmg.2024.08.005","article-title":"Mavacamten-associated temporal changes in left atrial function in obstructive HCM: insights from the VALOR-HCM Trial","volume":"18","author":"Desai","year":"2025","journal-title":"JACC Cardiovasc Imaging"},{"issue":"4","key":"10.1016\/j.hfc.2025.06.002_bib61","doi-asserted-by":"crossref","first-page":"339","DOI":"10.4070\/kcj.2024.0443","article-title":"Real-world experience of mavacamten for patients with obstructive hypertrophic cardiomyopathy in South Korea: a Prospective multi-Center study","volume":"55","author":"Lim","year":"2025","journal-title":"Korean Circ J"},{"key":"10.1016\/j.hfc.2025.06.002_bib62","doi-asserted-by":"crossref","first-page":"4854","DOI":"10.1038\/s41598-021-84335-1","article-title":"Sex differences in the prognosis of patients with hypertrophic cardiomyopathy","volume":"11","author":"Kim","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.hfc.2025.06.002_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2024.101235","article-title":"Long-term outcomes of patients with apical hypertrophic cardiomyopathy utilizing a new risk score","volume":"3","author":"Hajj-Ali","year":"2024","journal-title":"JACC Adv"},{"key":"10.1016\/j.hfc.2025.06.002_bib64","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jacasi.2023.12.001","article-title":"Machine learning-based discrimination of cardiovascular outcomes in patients with hypertrophic cardiomyopathy","volume":"4","author":"Rhee","year":"2024","journal-title":"JACC Asia"},{"key":"10.1016\/j.hfc.2025.06.002_bib65","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.124.036245","article-title":"Distinct phenotypic groups and related clinical outcomes in patients with hypertrophic cardiomyopathy","volume":"13","author":"Kwak","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hfc.2025.06.002_bib66","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.hrthm.2021.12.016","article-title":"Relationship between life-threatening events and electromechanical window in patients with hypertrophic cardiomyopathy: a novel parameter for risk stratification of sudden cardiac death","volume":"19","author":"Song","year":"2022","journal-title":"Heart Rhythm"}],"container-title":["Heart Failure Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713625000510?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713625000510?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T21:38:49Z","timestamp":1760218729000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551713625000510"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":66,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S1551713625000510"],"URL":"https:\/\/doi.org\/10.1016\/j.hfc.2025.06.002","relation":{},"ISSN":["1551-7136"],"issn-type":[{"value":"1551-7136","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Redefining Left Ventricular Systolic Dysfunction in Hypertrophic Cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Heart Failure Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hfc.2025.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}